Cue Biopharma reported raising $30 Million in an initial SEC Form D filing, from an offering of $30 Million
Round Type
Venture
BostonBiotechnologyHealth CareTherapeuticsInvestors
Quick answer
Cue Biopharma raised $30 Million in a funding round, dated May 4, 2026. Investors: MDB Capital Group. Cue Biopharma is based in Boston, Massachusetts, United States.
- How much did Cue Biopharma raise?
- Cue Biopharma raised $30 Million in a funding round on May 4, 2026.
- Who invested in Cue Biopharma?
- MDB Capital Group is named as investors in this round.
- What does Cue Biopharma do?
- Cue Biopharma, a clinical-stage biopharmaceutical company is developing a novel class of therapeutic biologics to selectively engage and modulate disease-relevant T cells for the treatment of autoimmune disease.
- Where is Cue Biopharma based and how big is it?
- Cue Biopharma is based in Boston, Massachusetts, United States. Fundz records about 29 employees.
- Who are the decision-makers at Cue Biopharma?
- Fundz holds 2 contacts at Cue Biopharma, including the Biotech CEO | Board Member & Chairman| LifeScience Advisor. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Cue Biopharma that raised within 45 days of this round, from Fundz verified event records.
- Vedana raised $46M (Series A) on June 17, 2026.
- Aplagon raised $5.6M (Funding Round) on June 17, 2026.
- Racura Oncology raised $34M (Funding Round) on June 17, 2026.
- Vedana Therapeutics raised $46M (Series A) on June 17, 2026.
- Emmecell raised an undisclosed amount (Funding Round) on June 16, 2026.
- SpliSense raised $13M (Funding Round) on June 16, 2026.
Who to call at Cue Biopharma, and when
A new round usually means Cue Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cue Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cue Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cue Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cue Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cue Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.